Trial Profile
A phase II study of KOB 03 for the treatment of allergic rhinitis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Jan 2015
Price :
$35
*
At a glance
- Drugs KOB 03 (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Therapeutic Use
- 24 Jan 2015 New trial record